Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypofractionated Proton Therapy and Chemotherapy in NSCLC
NCT02172846Phase 1Completed
- Sponsor
- Washington University School of Medicine
- Start
- May 2014
- Primary completion
- Aug 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 1, open-label trial of paclitaxel and carboplatin in non-small cell lung cancer (NSCLC), sponsored by Washington University School of Medicine. Started May 2014; status: completed.
02
Drugs
paclitaxelcarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02172846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172846.